Guest guest Posted February 3, 2003 Report Share Posted February 3, 2003 Good News for Dallas Area Women! FYI National Silicone Implant Foundation | Dallas Headquarters " Supporting Survivors of Medical Implant Devices " 4416 Willow Lane Dallas, TX 75244-7537 ----- Original Message ----- From: <utswnews-admin@...> <utswnews@...> Sent: Monday, February 03, 2003 1:34 PM Subject: UT Southwestern News Release Feb. 3, 2003 (3 releases included) Media Contact: Roy Bode, 214-648-7500 or Philip Schoch, 214-648-3404 philip.schoch@... $10 MILLION SOLOMON GIFT ENDOWS GENERAL MEDICINE DIVISION, LAUNCHES SPECIAL PROGRAM FOR CLINICAL SERVICES AT UT SOUTHWESTERN DALLAS - UT Southwestern Medical Center at Dallas will use a $10 million gift from Mr. and Mrs. T. to help develop a model for clinical service in general internal medicine, enabling physicians and staff to center their attention on patients in a time when health care has become increasingly impersonal and perplexing. American medicine has been buffeted by massive change in the past decade. A technology explosion, managed-care systems intended to control rising costs and other developments have made obtaining medical attention more complex for patients, Dr. Kern Wildenthal, UT Southwestern president, observed. In addition, he pointed out, clinical programs at UT Southwestern have grown dramatically since the 1980s, straining the institution's ability to handle efficiently more than 400,000 referral outpatient visits last year while caring for thousands more patients in affiliated hospitals. , a Dallas businessman who is chairing UT Southwestern's Innovations in Medicine capital campaign, said the contribution he and his wife, Gay, are making will help highlight clinical service as an integral element of the $450 million drive to advance research and treatment programs. The gift will be made to Southwestern Medical Foundation from the T. and Gay F. Fund of Communities Foundation of Texas and the T. and Gay F. Advised Fund of The Dallas Foundation. " UT Southwestern's increased focus on improving patient services will require a major commitment of financial resources, " he said. " This new emphasis expands the scope, relevance and purpose of the campaign. UT Southwestern is prepared to make a commitment to revolutionize patient care with the help of private philanthropy. " In all, he said, about $100 million will be required to fund the clinical portion of the campaign. " Since becoming chairman of the capital campaign, I have had an opportunity to get an up close view of what UT Southwestern is doing, " he continued. " Gay's and my personal commitment at this level is a testimony to what we see as the importance of these efforts, their prospects for success and the opportunity that presents itself at this time to us and others to help the medical center achieve its goals. " Wildenthal said the s' support will allow implementation of enhanced services in UT Southwestern's general internal medicine division, whose physicians see the largest number of patients at the medical center. The division will be named the T. and Gay F. Division of General Internal Medicine in recognition of the couple's support. " The intent of the s is to enable general internal medicine to be a proving ground to perfect a seamless system of clinical care, combining exemplary patient-centered services with the latest technology and physician expertise, " he explained. " Because this is a key issue for the entire American health-care system, we hope our work will create a model for improved doctor patient relations in other environments around the country. " These are among the clinical initiatives that should simplify access of patients to their doctors, expedite their care and allow their physicians to provide more individual attention: --Emphasizing a more patient-centered culture in which the quality of clinical care and services matches UT Southwestern's world-class research and teaching. --Creating a streamlined appointment scheduling system, so patient visits to various specialists can be coordinated easily. --Implementing a new patient-friendly telephone system, so calls can be completed without delay and frustration. --Installing an electronic medical record system so all physicians involved in a case can simultaneously access data while maintaining confidentiality. --Enhancing customer-service training, performance measures, recognition and incentives for staff. --Making cutting-edge clinical treatment trials readily available to patients, and facilitating enrollment and participation in them. --Unifying management for all patient-related services so that accountability is clear. UT Southwestern drafted a detailed plan late last year after internal studies, consultation with a panel of experts from other well-known American medical centers, and site visits to other top clinics where both strengths and weaknesses were evaluated. Implementation of its primary stages has already begun. " UT Southwestern has achieved an international reputation over the past two decades, with recognized eminence in biomedical science, teaching and clinical expertise, " said Dr. Willis C. Maddrey, executive vice president for clinical affairs at UT Southwestern. " We now are focusing as well on the quality of the patient experience. We are committed to ensuring that the services and attention we give our patients is unsurpassed. " Dr. D. McConnell, executive vice president for administration, added, " Doctors and patients alike recognize that efficient, patient-friendly care is not only more pleasant but also contributes to successful medical outcomes. Together with the outstanding hospitals with which we are affiliated, UT Southwestern will build an integrated clinical delivery system that minimizes the bureaucracy of medicine and maximizes its quality. " , chairman of Austin Industries, leads a committee of more than 100 prominent civic and business leaders who have volunteered in UT Southwestern's current capital campaign. A year ago, he and his wife committed a lead gift of $1 million to the drive. " The more we learned about UT Southwestern and its plans, the more we became convinced that there is a unique opportunity at this point to achieve real breakthroughs both in the quality of clinical service and in research, " said. " Gay and I decided to increase our support significantly because we believe so strongly in what they are accomplishing. We are convinced that the development of new models of patient-centered care coupled to the best of modern technology will be important for the health care system nationally, as well as for North Texas patients. " A Dallas native, is a member of the boards of Belo, Hoblitzelle Foundation and Southwestern Medical Foundation. He has previously served as chairman of the Dallas Citizens Council, Dallas Together Forum, Greater Dallas Chamber and is involved in a number of other community organizations. A graduate of Southern Methodist University and Harvard University, he was named to the Texas Business Hall of Fame in 1996 and Texas Minority Business Advocate of the Year in 1995. Gay Ferguson , a homemaker, painter and interior designer, is an ardent supporter of a variety of civic and religious organizations. An honors graduate of UT Austin, she currently serves on the board of the Dallas County Community College District Foundation and on the advisory committee of the CONTACT Counseling and Crisis Line. " The dedicated support of Bill and Gay in our campaign generally, and for our initiative to enhance clinical care and service particularly, will enable UT Southwestern to achieve a new standard of excellence, " Wildenthal said. " Their foresight and the support of others who join them in this effort will surely be seen by future generations as one of the most lasting and significant contributions ever made to our community. " ### Media Contact: Horton 214-648-3404 rachel.horton@... (Sidebar to story) UT SOUTHWESTERN'S GENERAL INTERNAL MEDICINE DIVISION PROVIDES PRIMARY PATIENT CARE DALLAS – Feb. 3, 2003 – The division of general internal medicine at UT Southwestern Medical Center has a faculty of 37 physicians who last year treated more than 62,000 patients for illnesses ranging from allergies to heart disease. Internists work as primary-care physicians who diagnose and treat virtually all illnesses while referring complex cases to specialists. Common ailments treated by internists include diabetes, hypertension and pneumonia. " We're the traditional family doctor, excluding surgery and obstetrics, " said Dr. W. , chief of general internal medicine. " We do a little bit of everything. We're usually the first people that somebody calls when they're sick. " The division's faculty also are responsible for about half the teaching done by the Department of Internal Medicine – the medical center's largest department – which has 17 other divisions, including cardiology, infectious diseases and hematology/oncology, said , holder of the S.T. Family Distinguished Chair in Internal Medicine and the Eva A. Rosenthal Professorship in Internal Medicine. General internal medicine is the largest single clinical-care division at UT Southwestern. Its outpatient facilities are located at the W. Aston Ambulatory Care Center and at Parkland Memorial Hospital. Faculty members also provide inpatient care and conduct consultations at Zale Lipshy University Hospital, St. University Hospital and Parkland. In addition, faculty clinicians at UT Southwestern also provide care to patients at Children's Medical Center of Dallas, the Dallas Veterans Affairs Medical Center, the UT Southwestern Moncrief Cancer Center in Fort Worth and a number of other affiliated hospitals and clinics in Dallas, Fort Worth and surrounding areas. Internists make initial assessments of a patient's needs and arrange appropriate medical care, said Dr. Ellwood , professor of internal medi cine. " Our job is to try to get the big picture and to coordinate care, " he said. " Our patients may have multiple medical problems, so communication is key with us, whether it be with other specialists, insurance providers or the patients themselves. " General internal medicine faculty physicians teach the physical diagnosis courses for first- and second-year medical students at Southwestern Medical School, said Dr. Al , associate dean for practice development, and holder of the Tim and Toni Hartman Professorship in Medicine. They also instruct third- and fourth-year students in general medicine in the wards and clinics of Parkland. " Preventive care is another main focus for doctors of internal medicine, " said. They encourage patients to schedule regular check-ups, which give health-care providers an opportunity to screen for diseases such as cancer, and counsel the patients about diet and exercise. " We are responsible for ensuring general preventive care, whether it be making sure that patients are getting annual mammograms and Pap smears, educating them about the symptoms of colon cancer, or monitoring cholesterol levels, " said Dr. Leach, associate professor of internal medicine and holder of the Irene Wadel and Atha Professorship of Internal Medicine, in Honor of W. Burnside, M.D. Physicians also conduct preoperative medical risk assessments to help predict and prevent any complications of surgery or general anesthesia, said. The general internal medicine division's annual operating budget is about $10 million. In addition to the faculty, the division employs 34 staff members in its Aston clinic and 18 in its academic office. UT Southwestern is re-naming the division as the T. and Gay F. Division of General Internal Medicine, in recognition of the 's historic $10 million endowment gift. With support provided by the gift, general internal medicine physicians and staff will be the first to begin comprehensive implementation of UT Southwestern's new initiative to provide patient-centered care and service. ### Media Contact: Maier 214-648-3404 scott.maier@... UT SOUTHWESTERN RESEARCHERS DEVELOPING NEW PROCEDURES TO MAKE BONE-MARROW TRANSPLANTS SAFER DALLAS – Feb. 4, 2003 – Researchers at UT Southwestern Medical Center at Dallas are helping develop new procedures that may reduce infections and diseases resulting from bone-marrow transplants. The work by Dr. Ellen Vitetta, director of the Cancer Immunobiology Center, and Dr. , director of the UT Southwestern Hematopoietic Cell Transplant Program, is part of research at UT Southwestern designed to identify the problem cells in a bone-marrow transplant and eliminate them before the transplant is carried out. The latest findings will appear in the Feb. 4 issue of the Proceedings of the National Academy of Sciences and online at the journal's Web site. In a bone-marrow transplant, the patient is treated with very high doses of chemotherapy, with or without radiation, to destroy cancer cells. This process also destroys the bone marrow, which is replaced with healthy marrow cells obtained either from the patient beforehand (autologous) or from a healthy donor (allogenic). Once transplanted, the donated bone-marrow cells multiply and repopulate the patient's blood cells. Allogenic stem cell transplants are preferred for many hematologic malignancies or inherited disorders. But while this type of transplant often has an anti-leukemic effect, the risk is graft-versus-host disease (GVHD), where the donated immune system (the graft) begins to attack the recipient's body (the host). If the graft T cells (lymphocytes) are depleted prior to transplant, GVHD is eliminated. However, there is no anti-leukemic effect, and the patients are at-risk for infection. " Graft-versus-host disease – when T cells are not eliminated and infections when they are – causes significant morbidity and mortality in patients, " said Vitetta, the study's senior author. To combat this problem, Vitetta and are developing and refining an in-vitro procedure to activate the donor T cells responsible for causing GVHD. These activated T cells are then eliminated with an immunotoxin against the cellular activation marker, CD25. This removes the cells responsible for GVHD, but spares cells responsible for the anti-leukemic activity and for fighting infections. Immunotoxins are drugs created by linking an antibody to a portion of bacterial or plant toxin to destroy cells expressing the molecule to which the antibody binds. " One of the major goals – the Holy Grail of bone-marrow transplantation – is to separate graft-versus-host disease from graft-versus-leukemia, and we're still not sure it can be done. But, what we've seen so far is very encouraging. If this approach proves successful, it would make transplants a lot safer and more widely utilized, " said . In a recent clinical study in France, Vitetta's group showed the incidence of GVHD was greatly reduced in patients who were infused with the treated cells. " What came out of the French trial is that this procedure is the way to go, " Vitetta said. " Now, we're trying to refine our work and see how broadly it can be applied. " A study by will open soon at UT Southwestern involving both related and unrelated bone-marrow transplant recipients. Instead of getting a full complement of T cells from the donor, he said, patients will receive T cells that have been selectively depleted of the allo-reactive T cells that researchers believe cause graft-versus-host disease. In addition to this work, Vitetta and are investigating whether T cells that cause GVHD can be distinguished from T cells with anti-leukemia activity. This is accomplished by generating clones of the two types of receptors and sequencing them. Their in-vitro research, featured in the Proceedings of the National Academy of Sciences article, has shown there are separate donor T cells that respond to the patient's normal cells and leukemia cells. " The goal is to get rid of the T cells that cause damage and save the beneficial ones, " Vitetta said. " Even though we're in the early days, both in the clinical trials and in the laboratory research, this is very encouraging. " Importantly, it would really be the first time something like this has been done entirely in-house, without companies. We make the immunotoxin, do all the preclinical studies, file and get an IND (Investigational New Drug Application) with the FDA, and do the clinical study, all on-site. We are hoping this will be a flagship for future efforts in this and related areas. " Because a variety of disorders are treated with bone-marrow transplants, the use of immunotoxins to eliminate harmful cells prior to the transplant could have a significant impact in increasing transplant success rates and reducing hospital time. Bone-marrow transplants can benefit patients with several types of cancers, including leukemia, lymphoma, myeloma or aplastic anemia. Occasionally, those with certain genetic diseases of the blood (such as thalassemia, sickle-cell disease and severe combined immunodeficiency) receive transplants. " If you can eliminate graft-versus-host disease but retain or even enhance the other beneficial effects of T cells, this could be applied to a variety of malignancies that are sensitive to donor T cells, " said. " It could be utilized in patients who have greater degrees of mismatch and in older patients. If this works out and makes transplants a lot safer, then I know we're going to be doing a lot more transplants. " Vitetta hopes to see the procedure expanded into different areas, such as the treatment of breast, prostate and other cancers. " I'd like to see this apply to all transplants and become standard-operating procedure, " she said. " This could establish a new paradigm. " The research was partially supported by a grant from the Leukemia Association of North Central Texas. Other contributors to the Proceedings study included first author Dr. Jaroslav Michalek and Dr. Petra Vaclavkova, postdoctoral research fellows; H. Pasha Durrani, research technician; and L.E. Ruff and Dr. Douek at the National Institutes of Health. ### These news releases are available on our World Wide Web home page at http://www.utsouthwestern.edu/home_pages/news/ _______________________________________________ Utswnews mailing list Utswnews@... http://lists.utsouthwestern.edu/mailman/listinfo/utswnews Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.